data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
SPY
––%
QQQ
––%
BTC/USD
––%
DIA
––%
GLD
––%
TLT
––%
GlycoMimetics
(NASDAQ:GLYC)
$1.99
-0.06[-2.93%]
Last update: 1:53PM (Delayed 15-Minutes)
Get Real Time Here
Day Range1.92 - 2.0952 Wk Range0.51 - 2.43Open / Close2.07 / -Float / Outstanding32.8M / 52.4M
Vol / Avg.318.3K / 315.1KMkt Cap104.3MP/E-50d Avg. Price0.9
Div / Yield-Payout Ratio-Total Float32.8MEPS-0.16

GlycoMimetics Stock (NASDAQ:GLYC), Quotes and News Summary

GlycoMimetics Stock (NASDAQ: GLYC) stock price, news, charts, stock research, profile.

Day Range1.92 - 2.0952 Wk Range0.51 - 2.43Open / Close2.07 / -Float / Outstanding32.8M / 52.4M
Vol / Avg.318.3K / 315.1KMkt Cap104.3MP/E-50d Avg. Price0.9
Div / Yield-Payout Ratio-Total Float32.8MEPS-0.16
Vandana Singh - Sep 24, 2021, 6:57AM
Business Wire - Nov 9, 2022, 7:00AM
Business Wire - Nov 8, 2022, 4:05PM
Business Wire - Nov 3, 2022, 9:00AM
Business Wire - Nov 2, 2022, 7:00AM
Business Wire - Sep 9, 2022, 8:30AM
Business Wire - Sep 7, 2022, 7:00AM
Business Wire - Sep 6, 2022, 7:00AM
Business Wire - Aug 3, 2022, 7:00AM
Business Wire - Jul 27, 2022, 4:00PM
Business Wire - Jun 2, 2022, 4:00PM
Business Wire - Apr 28, 2022, 7:30AM
Business Wire - Apr 25, 2022, 9:00AM
Business Wire - Mar 8, 2022, 4:30PM
Business Wire - Mar 3, 2022, 4:15PM
Business Wire - Mar 3, 2022, 7:30AM
Business Wire - Mar 2, 2022, 9:15AM
Business Wire - Feb 25, 2022, 9:00AM
Business Wire - Feb 23, 2022, 4:30PM
Business Wire - Feb 23, 2022, 4:00PM
Business Wire - Dec 13, 2021, 9:00AM
Business Wire - Dec 6, 2021, 9:15AM
InvestorsObserver - 6 days ago
TipRanks - Nov 21, 2022, 8:51AM
InvestorsObserver - Nov 21, 2022, 5:48AM
InvestorsObserver - Nov 17, 2022, 10:34AM
InvestorsObserver - Nov 15, 2022, 1:54PM
InvestorsObserver - Nov 14, 2022, 10:27AM
InvestorsObserver - Nov 11, 2022, 12:31PM
Seeking Alpha - Nov 11, 2022, 11:22AM
TipRanks - Nov 9, 2022, 12:30PM
Seeking Alpha - Nov 9, 2022, 11:10AM
Seeking Alpha - Sep 6, 2022, 7:10AM
Seeking Alpha - Aug 3, 2022, 4:08PM
InvestorsObserver - Aug 3, 2022, 11:45AM
TipRanks - Aug 3, 2022, 11:45AM
TipRanks - Jun 16, 2022, 8:18AM
TipRanks - Jun 16, 2022, 8:18AM
Seeking Alpha - Apr 30, 2022, 4:52PM
TipRanks - Apr 28, 2022, 11:05AM
Seeking Alpha - Apr 28, 2022, 7:43AM
InvestorsObserver - Mar 28, 2022, 3:16PM
InvestorsObserver - Mar 22, 2022, 4:16PM
Seeking Alpha - Mar 16, 2022, 1:06PM
Seeking Alpha - Mar 16, 2022, 11:54AM
InvestorsObserver - Mar 3, 2022, 2:43PM
TipRanks - Mar 3, 2022, 12:35PM
Seeking Alpha - Mar 3, 2022, 11:47AM
InvestorsObserver - Feb 25, 2022, 2:32PM
InvestorsObserver - Feb 17, 2022, 2:16PM
InvestorsObserver - Feb 11, 2022, 2:31PM
TipRanks - Jan 16, 2022, 7:14AM
Sector: Health Care.Industry: Biotechnology
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.
Read More

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.260-0.160 0.1000
REV0
Q2 2022Est.ActualSurprise
EPS-0.280-0.250 0.0300
REV75.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy GlycoMimetics (GLYC) stock?

A

You can purchase shares of GlycoMimetics (NASDAQ: GLYC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are GlycoMimetics's (GLYC) competitors?

Q

What is the target price for GlycoMimetics (GLYC) stock?

A

The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by HC Wainwright & Co. on Thursday, August 4, 2022. The analyst firm set a price target for 13.00 expecting GLYC to rise to within 12 months (a possible 553.27% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for GlycoMimetics (GLYC)?

A

The stock price for GlycoMimetics (NASDAQ: GLYC) is $1.99 last updated Today at November 28, 2022, 6:53 PM UTC.

Q

Does GlycoMimetics (GLYC) pay a dividend?

A

There are no upcoming dividends for GlycoMimetics.

Q

When is GlycoMimetics (NASDAQ:GLYC) reporting earnings?

A

GlycoMimetics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.

Q

Is GlycoMimetics (GLYC) going to split?

A

There is no upcoming split for GlycoMimetics.

Q

What sector and industry does GlycoMimetics (GLYC) operate in?

A

GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.